Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Progyny Q3 2025 Earnings Call - Strong Selling Season and Raised Guidance Amid Market Headwinds
Progyny delivered a robust Q3 2025 with revenue and profitability surpassing guidance expectations, driven by sustained member engagement and an energized selling season despite macroeconomic and medi...
- Progyny raised its full year 2025 revenue guidance for the third consecutive quarter, now up by over $70 million from original estimates.
- Q3 revenue growth was 9% on an as-reported basis and 23% excluding a large former client under a transition agreement.
- Approximately 900,000 new covered lives were added in the current selling season, slightly below the 1 million target but above expectations.
- +13 more takeaways
Natera 2025 Third Quarter Earnings Call - Record Signatera Growth, Strong Financial Outlook, and Expansion into Early Cancer Detection
Natera delivered a robust Q3 2025, with revenue up 35% year-over-year to $592 million and record clinical MRD test volumes exceeding 202,000 units, driven by significant growth in Signatera. The compa...
- Natera reported Q3 2025 revenue of $592 million, up 35% year-over-year, with strong volume growth across its clinical product portfolio.
- Signatera MRD tests hit a new high at 202,000 units processed, growing 56% year-over-year, driven by broad tumor type adoption and new patient starts.
- Gross margins improved significantly to 64.9% in Q3, nearly 1.5 percentage points higher than Q2, supported by ASP improvements and operational efficiencies.
- +7 more takeaways
Motorsport Games Q3 2025 Earnings Call - Profitability Achieved on Back of Le Mans Ultimate Growth and Console Expansion Plans
Motorsport Games reported a profitable third quarter in 2025, driven by strong sales growth in its flagship product Le Mans Ultimate and its online subscription platform Race Control. Having exited St...
- Motorsport Games achieved operational profitability for the second consecutive quarter in Q3 2025.
- Total revenue in Q3 2025 rose 71.9% year-over-year to $3.1 million, primarily from Le Mans Ultimate and Race Control.
- Le Mans Ultimate exited Steam Early Access with record-high concurrent and daily active users, independent of real-world event timing.
- +9 more takeaways
Arlo Technologies Q3 2025 Earnings Call - Powered by Record SaaS Growth and Product Launch
Arlo Technologies delivered a record-breaking Q3 2025, driven by an exceptional surge in its SaaS business and the largest product launch in company history. The company added 281,000 paid accounts, s...
- Arlo added 281,000 paid subscriber accounts in Q3, surpassing its guidance range of 190,000-230,000, pushing total paid accounts to 5.4 million.
- Annual recurring revenue (ARR) rose 34% year-over-year to $323 million, marking a new company record.
- Service gross margins expanded by 770 basis points to over 85%, driven by increased ARPU and reduced cost to serve.
- +12 more takeaways
Cherry Hill Mortgage Investment Corporation 3Q 2025 Earnings Call - Strategic Dividend Cut and Portfolio Shifts Amid Fed Easing
Cherry Hill Mortgage Investment Corporation reported a steady third quarter as macro volatility eased and markets settled into anticipation of Fed rate cuts, which came through in September and Octobe...
- Fed cut interest rates twice in Q3 and early Q4, creating a lower rate environment.
- Cherry Hill shifted RMBS portfolio towards lower and middle coupon mortgages to benefit from spread tightening and lower rates.
- MSR portfolio has a weighted average note rate of 3.5%, significantly below current mortgage rates, limiting refinancing risk.
- +9 more takeaways
Allbirds Q3 2025 Earnings Call - New Product Momentum Offsetting Legacy Challenges Amid Tight Margin and Liquidity Management
Allbirds reported Q3 2025 results reflecting a company in transition. The quarter showed mixed outcomes: new product launches like the Wool Cruiser and Waterproof Collection resonated well, lifting co...
- Q3 net revenue totaled $33 million, at the low end of guidance with mixed product performance.
- New product launches like the Wool Cruiser and 100% Waterproof Collection are exceeding expectations and driving brand revitalization.
- Legacy products such as the Original Runner franchise remain slow to recover, indicating ongoing brand rebuilding work.
- +7 more takeaways
EverCommerce Q3 2025 Earnings Call - Strategic AI Acquisition and Strong SaaS Growth Drive Margin Expansion
EverCommerce reported Q3 2025 revenue of $147.5 million, up 5.3% year-over-year, within guidance, with adjusted EBITDA reaching $46.5 million, reflecting a 31.5% margin—up 140 basis points. The quarte...
- EverCommerce delivered Q3 2025 revenue of $147.5 million, growing 5.3% year-over-year within guidance ranges.
- Adjusted EBITDA reached $46.5 million with a 31.5% margin, expanding 140 basis points YoY.
- The acquisition of Zyratok, an AI agentic platform focused on field services, is central to EverCommerce’s AI acceleration strategy.
- +17 more takeaways
QuinStreet Fiscal Q1 2026 Earnings Call - Record Revenue and Margin Expansion Amidst Tariff Uncertainty
QuinStreet reported a strong fiscal first quarter of 2026 with record revenue of $285.9 million and adjusted EBITDA of $20.5 million, surpassing their outlook. Auto insurance demand remained robust, g...
- QuinStreet achieved record fiscal Q1 2026 revenue of $285.9 million, exceeding guidance.
- Adjusted EBITDA reached $20.5 million, supported by strong auto insurance and home services segments.
- Auto insurance revenue grew 4% year-over-year and 16% sequentially, driven by proprietary media campaigns and product expansion.
- +7 more takeaways
Lineage Cell Therapeutics Q3 2025 Earnings Call - Progress and Optimism on OpRegen and Pipeline Expansion
Lineage Cell Therapeutics reported solid third quarter 2025 results, emphasizing robust progress in its OpRegen program and strategic pipeline expansion. The company highlighted Genentech's accelerati...
- Genentech expanded the number of clinical sites for the OpRegen phase 2A GALLOP study from seven to 15 in six months, a rapid pace compared to only one site added in 2024, suggesting increased clinical momentum.
- OpRegen has demonstrated durable improvements in retinal structure and visual acuity in prior phase 1/2A data, with independent validation from other groups using similar RPE cell approaches, bolstering its commercial potential.
- Roche streamlined its pipeline in 2024 but retained OpRegen, subsequently expanding services collaboration and obtaining RMAT designation for the program, indicating strong strategic commitment.
- +7 more takeaways
Xponential Fitness Q3 2025 Earnings Call - Focused Growth and Operational Streamlining Amid Boutique Fitness Maturity
Xponential Fitness reported a mixed third quarter in 2025, highlighting robust franchisee commitment and strong growth in new Club Pilates studios, which continue to set records for year-one revenue r...
- Xponential fitness completed three recent brand divestitures, resulting in a streamlined portfolio focused on five core brands: Club Pilates, Pure Barre, YogaSix, BFT, and StretchLab.
- CEO Mike Nuzzo emphasized that boutique fitness shows strong long-term growth potential, with U.S. participation at a record 247 million exercisers in 2024 and a projected $60 billion global boutique market by 2030.
- Club Pilates leads the portfolio with over 1,200 North American locations and strong international presence; recent cohorts are showing record year-one revenue growth, with average unit volumes (AUVs) approaching $1 million.
- +12 more takeaways